Understanding how CD8+ T cells activate the immune system
Official title: Mechanisms of CD8+ T cell-induced Innate Immune Activation
Funded at Cincinnati Childrens Hosp Med Ctr · NIH-11065676 · Data updated 2026-11-12
This study is looking at how a type of immune cell called CD8+ T cells helps kickstart the body's defense against infections and cancer, and it’s for anyone interested in understanding how we can improve treatments for these health issues.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cincinnati Childrens Hosp Med Ctr NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project start | November 18, 2024 |
| Project end | November 17, 2028 |
| Funding year | 2025 |
| Award (this year) | $41,915 |
| NIH project number | 1F30AI188599-01 |
| Project ID | NIH-11065676 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include patients with cancer or chronic infections who may benefit from enhanced immune responses.
✕Less likely to help
Patients with autoimmune disorders or those who do not have a significant immune response may not benefit from this research.
What this research studies
This research investigates the role of CD8+ T cells in activating the innate immune system, particularly how these cells can trigger inflammatory responses against pathogens and cancer. The study focuses on the mechanisms by which memory CD8+ T cells interact with myeloid cells to produce important cytokines that help fight infections and tumors. By examining these interactions, the research aims to uncover new insights into immune responses that could enhance therapies for various diseases.
Why it matters
Potential benefit: If successful, this research could lead to improved immunotherapies for cancer and infectious diseases by harnessing the power of CD8+ T cells.
How similar studies have gone: Previous research has shown promising results in understanding T cell interactions with the immune system, suggesting that this approach could yield valuable insights.
Where this research is happening
-
Cincinnati Childrens Hosp Med Ctr
Cincinnati, United States Active
Researchers
- Principal investigator: Vallez, Charles — Cincinnati Childrens Hosp Med Ctr
- Study coordinator: Vallez, Charles
Related research
Other NIH-funded projects on the same topics.
-
Accelerating Rheumatic Heart Disease Prevention in Uganda
A program to find people with rheumatic heart disease in Ugandan communities and give them preventive care close to home.
-
Enhanced surveillance network to track childhood vaccines and viral infections in kids
A nationwide pediatric surveillance network will closely watch how common viruses and vaccines affect children’s health, using standard protocols at hospital and ED sites.
-
Advancing CNS drug delivery through epigenetic tweaks
A medical research project aims to help people with lysosomal storage disorders by improving how treatments reach the brain.
-
Spina Bifida Registry for Better Clinic Care
A national registry project aims to improve care for people with spina bifida by collecting and sharing data from multidisciplinary clinics to guide evidence-based practices.
-
Hydroxyurea to help children with sickle cell anemia in Africa
A pediatric study tests hydroxyurea treatment for young children with sickle cell anemia in several African countries to see if it can reduce illness and improve health.
-
Hydroxyurea for Children with Sickle Cell in Africa
A pilot study tests hydroxyurea in young children with sickle cell disease across several African countries to see if it can reduce illness and hospital visits.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.